Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1fbe98f277a1db1221209dc2522a2770 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2f748a07c1a2a8433219e7737f7b891 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d435af1334506543853ecfdd8e665f27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_436d935405b70657a3d8b95f00b4f195 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3c951b1a2fde972142028454017ed187 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-064 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-0028 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61J1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-46 |
filingDate |
2004-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d28648f1177d696c00b535cd019a9dec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9824e779255a0dcdaad5d25a33669d20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c8c08fd4b9d320a0c731be7464212e5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_804dec20eef1a5fbb50ea46f44700f07 |
publicationDate |
2005-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2005053647-A1 |
titleOfInvention |
Medical product containing tiotropium |
abstract |
The invention discloses a medical product comprising a dry powder medicament dose and a container adapted for use in a dry powder inhaler, where by the dry powder medicament dose is loaded into the container. The dry powder medicament dose comprises particles of tiotropium and particles having a mass median diameter of 10 µm or more of at least one dry excipient; and the container constitutes a dry, high barrier seal preventing ingress of moisture and preserving the dry powder medicament dose. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011037549-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011037551-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11090294-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11116721-B2 |
priorityDate |
2003-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |